Surojit Sarkar

Surojit Sarkar

Auto-generated profile, based on publicly available information

Surojit Sarkar

Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute, Seattle WA 98101

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
VKVandana Kalia
Vandana Kalia
SSSurojit Sarkar
Surojit Sarkar
Interleukin-2 (IL-2) regulates key aspects of CD8 T cell biology–signaling through distinct pathways IL-2 triggers critical metabolic and transcriptional changes that lead to a spectrum of physiological outcomes such as cell survival, proliferation, and effector differentiation. In addition to driving effector differentiation, IL-2 signals are also critical for formation of long-lived CD8 T cell memory. This review discusses a model of rheostatic control of CD8 T cell effector and memory differentiation by IL-2, wherein the timing, duration, dose, and source of IL-2 signals are considered in fine-tuning the balance of key transcriptional regulators of cell fate.

1 June 2015 in Immunity
Verified
Journal Article
Closed access
VKVandana Kalia
Vandana Kalia
LPLaura Anne Penny
Laura Anne Penny
YYYevgeniy Yuzefpolskiy
Yevgeniy Yuzefpolskiy
FBFlorian Martin Baumann
Florian Martin Baumann
SSSurojit Sarkar
Surojit Sarkar

13 October 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
VKVandana Kalia
Vandana Kalia
YYYevgeniy Yuzefpolskiy
Yevgeniy Yuzefpolskiy
AVAdithya Vegaraju
Adithya Vegaraju
HXHanxi Xiao
Hanxi Xiao
FBFlorian Baumann
Florian Baumann
SSSurojit Sarkar
Surojit Sarkar
PD-1 signals promote development of long-lived quiescent memory CD8 T cells by regulating the balance of glycolysis and fatty acid oxidation.

28 July 2014 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
YYYevgeniy Yuzefpolskiy
Yevgeniy Yuzefpolskiy
FBFlorian M. Baumann
Florian M. Baumann
VKVandana Kalia
Vandana Kalia
SSSurojit Sarkar
Surojit Sarkar
Early after priming, effector CD8 T cells are distinguished into memory precursor and short-lived effector cell subsets (MPECs and SLECs). Here, we delineated a distinct in vivo heterogeneity in killer cell lectin-like receptor G1 (KLRG-1) expression, which was strongly associated with diverse MPEC and SLEC fates. These in vivo MPECs and SLECs expressed equivalent levels of cytotoxic molecules and effector cytokines. Using a unique in vivo degranulation assay, we found that the MPECs and SLECs similarly encountered infected target cells and elaborated equivalent levels of cytotoxicity in vivo. These data provide direct in vivo evidence that memory-fated cells pass through a robust effector phase. Additionally, the preferential localization of the MPECs in the lymph nodes, where a lesser degree of cytotoxicity was elaborated, suggests that the MPECs may be protected from excessive stimulation and terminal differentiation by virtue of their differential tissue localization. These data provide novel mechanistic insights into the linear decreasing potential model of memory differentiation.

13 April 2022 in Cell Reports
Verified
Journal Article
Open access
RTRyma Toumi
Ryma Toumi
YYYevgeniy Yuzefpolskiy
Yevgeniy Yuzefpolskiy
AVAdithya Vegaraju
Adithya Vegaraju
HXHanxi Xiao
Hanxi Xiao
KSKendall A. Smith
Kendall A. Smith
VKVandana Kalia
Vandana Kalia
Differential interleukin-2 (IL-2) signaling and production are associated with disparate effector and memory fates. Whether the IL-2 signals perceived by CD8 T cells come from autocrine or paracrine sources, the timing of IL-2 signaling and their differential impact on CD8 T cell responses remain unclear. Using distinct models of germline and conditional IL-2 ablation in post-thymic CD8 T cells, this study shows that paracrine IL-2 is sufficient to drive optimal primary expansion, effector and memory differentiation, and metabolic function. In contrast, autocrine IL-2 is uniquely required during primary expansion to program robust secondary expansion potential in memory-fated cells. This study further shows that IL-2 production by antigen-specific CD8 T cells is largely independent of CD4 licensing of dendritic cells (DCs) in inflammatory infections with robust DC activation. These findings bear implications for immunizations and adoptive T cell immunotherapies, where effector and memory functions may be commandeered through IL-2 programming.

15 December 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SSSurojit Sarkar
Surojit Sarkar
YYYevgeniy Yuzefpolskiy
Yevgeniy Yuzefpolskiy
HXHanxi Xiao
Hanxi Xiao
FBFlorian M. Baumann
Florian M. Baumann
SYSoojin Yim
Soojin Yim
VKVandana Kalia
Vandana Kalia
IL-1, generally considered an amplifier of adaptive immune responses, has been proposed for use as adjuvant during immunization with weak immunogens. However, its effects on memory T cell function remain largely undefined. Using the murine model of acute viral infection, in this paper, we show that in addition to augmenting the size of the Ag-specific pool, IL-1 signals act directly on CD8 T cells to promote the quality of effector and memory responses. Ablation of IL-1R1 or MyD88 signaling in T cells led to functional impairment; both the ability to produce multiple cytokines on a per cell basis (polyfunctionality) and the potential for recall proliferation in response to antigenic restimulation were compromised. IL-1 supplementation during priming augmented the expansion of Ag-specific CD8 T cells through the MyD88–IRAK1/4 axis, resulting in a larger memory pool capable of robust secondary expansion in response to rechallange. Together, these findings demonstrate a critical role of the IL-1–MyD88 axis in programming the quantity and quality of memory CD8 T cell responses and support the notion that IL-1 supplementation may be exploited to enhance adoptive T cell therapies against cancers and chronic infections.